8 completed. 8 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 8 | Completed 8 |
| Phase 2 | 1 | Completed 1 |
Follow Anorexia: new trials by email Literature Review of Anorexia trials Research Report on Anorexia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and Anorexia PF-06946860, Placebo for PF-06946860 - Non-small Cell Lung Cancer, Pancreatic Cancer | Phase 1 | Completed | Pfizer | 18 | 2021-05-11 | 2024-01-12 |
| Study to Assess the Safety and Tolerability of Repeated Doses of an Investigational New Drug in Patients With Cancer and Cachexia. PF-06946860 - Cachexia, Non-Small-Cell Lung Cancer | Phase 1 | Completed | Pfizer | 11 | 2020-11-17 | 2023-12-14 |
| Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S QBS10072S - Astrocytoma, Brain Cancer | Phase 1 | Completed | Quadriga Biosciences, Inc. | 15 | 2020-07-20 | 2023-01-18 |
| Repetitive Transcranial Magnetic Stimulation of the DMPFC for Anorexia and Bulimia: an Open-Label Case Series Repetitive Transcranial Magnetic Stimulation - Bulimia Nervosa, Anorexia Nervosa | Phase 1 | Completed | University Health Network, Toronto | 60 | 2011-12-11 | 2020-06-01 |
| Pharmacokinetics of Megace F and Megace OS Under Fasting and Fed Conditions in Healthy Male Volunteers Megace F, Megace OS - Cachexia, Anorexia | Phase 1 | Completed | Boryung Pharmaceutical Co., Ltd | 103 | 2011-07-01 | 2012-07-02 |
| Safety & Tolerability of a Combination of Antidepressant and Peptic Ulcer Drug in Overweight Healthy Subjects Sertraline plus Telenzepine - Obesity | Phase 1 | Completed | Theracos | 40 | 2010-05-01 | 2019-06-17 |
| Safety Study of a Rotavirus Vaccine (Rotavin-M1) Among Healthy Adults Rotavin - Diarrhea, Vomit | Phase 1 | Completed | National Institute of Hygiene and Epidemiology, Vietnam | 29 | 2009-08-01 | 2016-07-04 |
| Palonosetron for Prevention of Biochemotherapy Induced Nausea and Vomiting Palonosetron - Melanoma | Phase 1 / Phase 2 | Completed | M.D. Anderson Cancer Center | 30 | 2006-11-01 | 2012-05-04 |
Weight Loss (4) · Cachexia (3) · Colorectal Neoplasms (3) · Pancreatic Neoplasms (3) · Vomiting (3) · Breast Neoplasms (2) · Carcinoma, Non-Small-Cell Lung (2) · Fatigue (2) · Melanoma (2) · Nausea (2) · Neoplasms (2) · Ovarian Neoplasms (2) · Prostatic Neoplasms (2) · Anorexia Nervosa (1)
Pathological Conditions, Signs and Symptoms (8) · Signs and Symptoms (8) · Signs and Symptoms, Digestive (8) · Body Weight (5) · Body Weight Changes (5) · Neoplasms by Site (4) · Colonic Diseases (3) · Digestive System Diseases (3) · Digestive System Neoplasms (3) · Endocrine Gland Neoplasms (3) · Endocrine System Diseases (3) · Gastrointestinal Diseases (3) · Gastrointestinal Neoplasms (3) · Intestinal Diseases (3) · Intestinal Neoplasms (3)
Palonosetron (1) · Sertraline (1) · Transcranial Magnetic Stimulation (1) · telenzepine (1)
Pfizer (2) · Boryung Pharmaceutical Co., Ltd (1) · M.D. Anderson Cancer Center (1) · National Institute of Hygiene and Epidemiology, Vietnam (1) · Quadriga Biosciences, Inc. (1) · Theracos (1) · University Health Network, Toronto (1)
United States (3) · Australia (1) · Canada (1) · South Korea (1) · Vietnam (1)
Agop Y. Bedikian, MD (1) · Anh D Dang, PhD (1) · Blake Woodside, MD (1) · Jolene Berg, MD (1) · Jonathan Downar, MD (1) · Kyung-sang Yu, Dr. (1)